Latest Breaking News On - உலகளாவிய நிறுவனம் க்கு நோய் நீக்குதல் - Page 1 : comparemela.com

Oxford Malaria Vaccine Trial Points to Disease ‘Game-Changer’ Bloomberg 1 hr ago Janice Kew (Bloomberg) The first malaria vaccine to meet a World Health Organization specified goal of more than 75% efficacy has been developed by scientists at the University of Oxford, a potentially significant step toward defeating the disease. Finding more effective inoculations against the mosquito-borne disease has been a critical goal in fighting an infection that kills about 400,000 people a year, largely in sub-Saharan Africa, with most being children under the age of five. “Even before COVID-19, progress in the global fight against malaria had stalled,” said Simon Bland, chief executive officer of the Global Institute for Disease Elimination. “This new vaccine could be a game-changer toward the elimination of malaria, a disease that has killed more people than any other since the beginning of humankind.”

Burkina fasoGareth jenkinsUniversity of oxfordWorld health organizationJenner instituteGlobal institute for disease eliminationSerum institute of indiaOxford astrazeneca plcNovavax incSaharan africaSimon blandGlobal instituteSerum instituteDisease eliminationபுர்கினா ஃபாஸொகரேத் ஜென்கின்ஸ்